Coronavirus vaccine trumps divided government in turbocharging markets: Goldman Sachs Leave a comment

Pfizer and German partner BioNTech announced on Monday that their COVID-19 vaccine candidate, which was developed in record time, was found to have a 90% positive efficacy rate and could start being distributed before the end of the year.

Leave a Reply

Your email address will not be published. Required fields are marked *


Generated by Feedzy